196 related articles for article (PubMed ID: 38730417)
1. Interval training suppresses nod-like receptor protein 3 inflammasome activation to improve cardiac function in myocardial infarction rats by hindering the activation of the transforming growth factor-β1 pathway.
Wei W; Xie P; Wang X
J Cardiothorac Surg; 2024 May; 19(1):283. PubMed ID: 38730417
[TBL] [Abstract][Full Text] [Related]
2. Anti-hyperlipidemic, Anti-inflammatory, and Ameliorative Effects of DRP1 Inhibition in Rats with Experimentally Induced Myocardial Infarction.
Chen X; Liang J; Bin W; Luo H; Yang X
Cardiovasc Toxicol; 2021 Dec; 21(12):1000-1011. PubMed ID: 34472022
[TBL] [Abstract][Full Text] [Related]
3. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
4. CircRNA 010567 improves myocardial infarction rats through inhibiting TGF-β1.
Bai M; Pan CL; Jiang GX; Zhang YM
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):369-375. PubMed ID: 31957851
[TBL] [Abstract][Full Text] [Related]
5. Serelaxin inhibits the profibrotic TGF-β1/IL-1β axis by targeting TLR-4 and the NLRP3 inflammasome in cardiac myofibroblasts.
Cáceres FT; Gaspari TA; Samuel CS; Pinar AA
FASEB J; 2019 Dec; 33(12):14717-14733. PubMed ID: 31689135
[TBL] [Abstract][Full Text] [Related]
6. Uric acid aggravates myocardial ischemia-reperfusion injury via ROS/NLRP3 pyroptosis pathway.
Shen S; He F; Cheng C; Xu B; Sheng J
Biomed Pharmacother; 2021 Jan; 133():110990. PubMed ID: 33232925
[TBL] [Abstract][Full Text] [Related]
7. NF-κB-Gasdermin D (GSDMD) Axis Couples Oxidative Stress and NACHT, LRR and PYD Domains-Containing Protein 3 (NLRP3) Inflammasome-Mediated Cardiomyocyte Pyroptosis Following Myocardial Infarction.
Lei Q; Yi T; Chen C
Med Sci Monit; 2018 Aug; 24():6044-6052. PubMed ID: 30161099
[TBL] [Abstract][Full Text] [Related]
8. Dual Role of Triptolide in Interrupting the NLRP3 Inflammasome Pathway to Attenuate Cardiac Fibrosis.
Pan XC; Liu Y; Cen YY; Xiong YL; Li JM; Ding YY; Tong YF; Liu T; Chen XH; Zhang HG
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30654511
[TBL] [Abstract][Full Text] [Related]
9. Possible mechanism by which renal sympathetic denervation improves left ventricular remodelling after myocardial infarction.
Zheng XX; Li XY; Lyu YN; He YY; Wan WG; Zhu HL; Jiang XJ
Exp Physiol; 2016 Feb; 101(2):260-71. PubMed ID: 26556551
[TBL] [Abstract][Full Text] [Related]
10. Celastrol relieves myocardial infarction-induced cardiac fibrosis by inhibiting NLRP3 inflammasomes in rats.
Fan J; Ren M; Chen W; Wang H; He Y
Int Immunopharmacol; 2023 Aug; 121():110511. PubMed ID: 37343368
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
12. Calhex231 ameliorates myocardial fibrosis post myocardial infarction in rats through the autophagy-NLRP3 inflammasome pathway in macrophages.
Liu W; Sun J; Guo Y; Liu N; Ding X; Zhang X; Chi J; Kang N; Liu Y; Yin X
J Cell Mol Med; 2020 Nov; 24(22):13440-13453. PubMed ID: 33043596
[TBL] [Abstract][Full Text] [Related]
13. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
[TBL] [Abstract][Full Text] [Related]
14. Kukoamine A activates Akt/GSK-3β signaling pathway to inhibit oxidative stress and relieve myocardial ischemia-reperfusion injury.
Xu H; Zhang G; Deng L
Acta Cir Bras; 2022; 37(4):e370407. PubMed ID: 35894345
[TBL] [Abstract][Full Text] [Related]
15. Ulinastatin protects rats with myocardial infarction by activating Nrf2/NOS pathway.
Wang S; Cheng ZY; Chen XJ; Xue HZ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8990-8998. PubMed ID: 30575944
[TBL] [Abstract][Full Text] [Related]
16. Sacubitril/valsartan (LCZ696) reduces myocardial injury following myocardial infarction by inhibiting NLRP3‑induced pyroptosis via the TAK1/JNK signaling pathway.
Shen J; Fan Z; Sun G; Qi G
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296299
[TBL] [Abstract][Full Text] [Related]
17. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice.
Gao RF; Li X; Xiang HY; Yang H; Lv CY; Sun XL; Chen HZ; Gao Y; Yang JS; Luo W; Yang YQ; Tang YH
Int Immunopharmacol; 2021 Jan; 90():107133. PubMed ID: 33168408
[TBL] [Abstract][Full Text] [Related]
18. Salvianolate reduces atrial fibrillation through suppressing atrial interstitial fibrosis by inhibiting TGF-β1/Smad2/3 and TXNIP/NLRP3 inflammasome signaling pathways in post-MI rats.
Qiu H; Liu W; Lan T; Pan W; Chen X; Wu H; Xu D
Phytomedicine; 2018 Dec; 51():255-265. PubMed ID: 30466624
[TBL] [Abstract][Full Text] [Related]
19. LuQi Formula Regulates NLRP3 Inflammasome to Relieve Myocardial-Infarction-Induced Cardiac Remodeling in Mice.
Zhang X; Zhao D; Feng J; Yang X; Lan Z; Yang T; Kong X; Qu H; Zhou H
Evid Based Complement Alternat Med; 2021; 2021():5518083. PubMed ID: 34257682
[TBL] [Abstract][Full Text] [Related]
20. Piperazine ferulate protects against cardiac ischemia/reperfusion injury in rat via the suppression of NLRP3 inflammasome activation and pyroptosis.
Lei Z; Luan F; Zhang X; Peng L; Li B; Peng X; Liu Y; Liu R; Zeng N
Eur J Pharmacol; 2022 Apr; 920():174856. PubMed ID: 35219728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
